Vimarsana
Biggest News Aggregation in the World

Page 11 - Biologically Inspired News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biologically Inspired. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biologically Inspired Today - Breaking & Trending Today

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer - Vimarsana News

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

Development by New Orleans biotech company to enable studies of human fat tissue in vitro ...

Obatala Sciences, Harvard partner on human fat tissue study - Vimarsana News

Obatala Sciences, Harvard partner on human fat tissue study

Obatala Sciences, Harvard partner on human fat tissue study New Orleans-based biotechnology firm Obatala Sciences has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro. The licensed Harvard technology, an adipose-on-a-chip, provides a method of obtaining adult-size fat tissue cells for study in vitro and enables the testing of weight loss and cancer-targeting therapeutics without the need for testing in animals, a news release said. It provides a more accurate and dynamic model of human tissue in its dise...

Torus Biosystems Raises $25M in Series A Funding - Vimarsana News

Torus Biosystems Raises $25M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M. Church, PhD - Vimarsana News

Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M. Church, PhD

Share this article Share this article HOUSTON, May 25, 2021 /PRNewswire/ -- AuraVax Therapeutics, Inc. (Auravax), a biotech company developing novel intranasal therapeutics and vaccines to help patients defeat debilitating respiratory diseases, including COVID-19, today announced the formation of its inaugural Scientific Advisory Board (SAB), consisting of leading experts in the fields of biology, vaccines and intranasal drug delivery. The SAB will guide and advise the company in its ongoing development of proprietary therapeutics and vaccines for respiratory diseases. The SAB is chaired by ...

Dyno, in demand for its gene therapy work, raises $100M for fast expansion - Vimarsana News

Dyno, in demand for its gene therapy work, raises $100M for fast expansion

Published May 6, 2021 Permission granted by Eric Kelsic / Dyno Therapeutics Dyno Therapeutics, a Harvard University spinout working to improve gene therapy, is expanding with $100 million in new funding from tech investor Andreessen Horowitz and several other venture firms. Since officially launching a year ago, Dyno has struck deals with Novartis, Roche and Sarepta Therapeutics to aid their efforts to develop more efficient delivery of gene therapy. But even after doubling in size to 50 employees, the company hasn't been able to keep up...